These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2025306)

  • 1. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.
    Reiter C; Kakavand B; Rieber EP; Schattenkirchner M; Riethmüller G; Krüger K
    Arthritis Rheum; 1991 May; 34(5):525-36. PubMed ID: 2025306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.
    Horneff G; Burmester GR; Emmrich F; Kalden JR
    Arthritis Rheum; 1991 Feb; 34(2):129-40. PubMed ID: 1994909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.
    Goldberg D; Morel P; Chatenoud L; Boitard C; Menkes CJ; Bertoye PH; Revillard JP; Bach JF
    J Autoimmun; 1991 Aug; 4(4):617-30. PubMed ID: 1777012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
    Herzog C; Walker C; Müller W; Rieber P; Reiter C; Riethmüller G; Wassmer P; Stockinger H; Madic O; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):627-42. PubMed ID: 2572230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody.
    Choy EH; Chikanza IC; Kingsley GH; Corrigall V; Panayi GS
    Scand J Immunol; 1992 Aug; 36(2):291-8. PubMed ID: 1354392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.
    Horneff G; Winkler T; Kalden JR; Emmrich F; Burmester GR
    Clin Immunol Immunopathol; 1991 Apr; 59(1):89-103. PubMed ID: 2019013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5).
    Racadot E; Wijdenes J; Wendling D
    Clin Exp Rheumatol; 1992; 10(4):365-74. PubMed ID: 1356679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone.
    Wendling D; Racadot E; Morel-Fourrier B; Wijdenes J
    Clin Rheumatol; 1992 Dec; 11(4):542-7. PubMed ID: 1486748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.
    Moreland LW; Pratt PW; Mayes MD; Postlethwaite A; Weisman MH; Schnitzer T; Lightfoot R; Calabrese L; Zelinger DJ; Woody JN
    Arthritis Rheum; 1995 Nov; 38(11):1581-8. PubMed ID: 7488278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells.
    Walker C; Herzog C; Rieber P; Riethmüller G; Müller W; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):643-9. PubMed ID: 2572231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.
    Moreland LW; Bucy RP; Tilden A; Pratt PW; LoBuglio AF; Khazaeli M; Everson MP; Daddona P; Ghrayeb J; Kilgarriff C
    Arthritis Rheum; 1993 Mar; 36(3):307-18. PubMed ID: 8095785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis.
    van der Lubbe PA; Reiter C; Breedveld FC; Krüger K; Schattenkirchner M; Sanders ME; Riethmüller G
    Arthritis Rheum; 1993 Oct; 36(10):1375-9. PubMed ID: 8216397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial.
    Choy EH; Panayi GS; Emery P; Madden S; Breedveld FC; Kraan MC; Kalden JR; Rascu A; Brown JC; Rapson N; Johnston JM
    Rheumatology (Oxford); 2002 Oct; 41(10):1142-8. PubMed ID: 12364634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies.
    Horneff G; Emmrich F; Burmester GR
    Br J Rheumatol; 1993 Jun; 32 Suppl 4():39-47. PubMed ID: 8099518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD4 modulation in vivo induced by antibody treatment.
    Horneff G; Guse AH; Schulze-Koops H; Kalden JR; Burmester GR; Emmrich F
    Clin Immunol Immunopathol; 1993 Jan; 66(1):80-90. PubMed ID: 8440076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-CD4 antibody for treatment of chronic inflammatory arthritis.
    Emmrich F; Horneff G; Becker W; Lüke W; Potocnik A; Kanzy U; Kalden JR; Burmester G
    Agents Actions Suppl; 1991; 32():165-70. PubMed ID: 2069085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens.
    Choy EH; Pitzalis C; Cauli A; Bijl JA; Schantz A; Woody J; Kingsley GH; Panayi GS
    Arthritis Rheum; 1996 Jan; 39(1):52-6. PubMed ID: 8546738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD4 monoclonal antibody administration in renal transplanted patients.
    Morel P; Vincent C; Cordier G; Panaye G; Carosella E; Revillard JP
    Clin Immunol Immunopathol; 1990 Sep; 56(3):311-22. PubMed ID: 2390809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action.
    van der Lubbe PA; Reiter C; Miltenburg AM; Krüger K; de Ruyter AN; Rieber EP; Bijl JA; Riethmüller G; Breedveld FC
    Scand J Immunol; 1994 Mar; 39(3):286-94. PubMed ID: 8128188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients.
    Choy EH; Connolly DJ; Rapson N; Jeal S; Brown JC; Kingsley GH; Panayi GS; Johnston JM
    Rheumatology (Oxford); 2000 Oct; 39(10):1139-46. PubMed ID: 11035136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.